Related Experiment Videos
Human Immunodeficiency Virus (HIV) in Children
1Department of Neurology, Division of Pediatric Neurology, College of Physicians and Surgeons, Columbia University, 710 West 168th Street, New York, NY 10032, USA. cac3@columbia.edu
Current Treatment Options in Neurology
|April 5, 2002
Summary
Advances in antiretroviral therapy have made pediatric HIV a manageable chronic condition. Neurologists must understand these complex treatments, including drug metabolism and side effects, for effective pediatric HIV care.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Pharmacology
Background:
- Antiretroviral therapy has significantly improved outcomes for children with HIV.
- HIV has transitioned from a fatal illness to a chronic, manageable condition in pediatric populations.
- Current antiretroviral treatments are complex and carry potential risks.
Purpose of the Study:
- To highlight the evolving landscape of pediatric HIV management.
- To emphasize the critical role of neurologists in caring for HIV-infected children.
- To underscore the importance of understanding antiretroviral drug metabolism and indications.
Main Methods:
- Review of recent advancements in pediatric HIV treatment.
- Analysis of the impact of highly active antiretroviral therapies (HAART) on HIV prognosis.
- Discussion of the complexities and potential side effects of antiretroviral agents.
Main Results:
- Perinatal HIV transmission rates have been substantially reduced.
- Highly active antiretroviral treatments (HAART) have largely rendered HIV a nonfatal chronic disorder in children.
- Antiretroviral therapies require careful management due to complexity and potential adverse effects.
Conclusions:
- Neurologists managing HIV-infected children need comprehensive knowledge of antiretroviral drugs.
- Understanding drug metabolism and specific treatment indications is crucial for optimizing care.
- Effective management of pediatric HIV relies on a deep understanding of current therapeutic strategies.